Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Thalassemia intermedia (TI) is an inherited blood disorder that can cause anemia due to low
levels of hemoglobin. Decitabine is a medication that may be effective at increasing
hemoglobin levels. This study will evaluate the safety and effectiveness of decitabine at
increasing hemoglobin levels in people with TI.